ğŸ“Š Bangladesh Generic Medicine Market Analysis â€” Power BI Project
ğŸ“Œ Project Overview

This project analyzes the Bangladesh Generic Medicine Market using Power BI.
It covers:

Market structure across Medicines, Generics, Drug Classes, Dosage Forms, Manufacturers & Indications

Price extraction from messy text fields

Market competitiveness

Key insights for anti-malarial, insulin, paracetamol IV, and anti-hypertensive medicines

Business recommendations for new entrants

The goal was to build an end-to-end analytical dashboard using cleaning, modeling, DAX, and visualization.

ğŸ“ Dataset Summary

You worked with 6 interconnected tables:

1. Medicines

Brand Name

Generic Name

Manufacturer Name

Dosage Form

Package Container

Dosage Size

Price Extracted

2. Generics

Generic ID

Generic Name

Drug Class

Indication

3. Drug Class

Drug Class ID

Drug Class Name

Generic Count

4. Dosage Form

Dosage Form ID

Dosage Form Name

Brand Count

5. Indication

Indication ID

Indication Name

Generic Count

6. Manufacturers

Manufacturer ID

Manufacturer Name

Generic Count

Brand Count

ğŸ”§ Data Cleaning & Transformation (Power Query)
âœ”ï¸ Extracted Price from â€œPackage Containerâ€

Split column by delimiter

Used Text.Split and Value.FromText logic

Standardized formats

Converted currency strings â†’ numeric values

âœ”ï¸ Cleaned Dosage Size

Extracted numbers (mg/ml/unit)

Separated quantity + unit

Removed brackets and noise text

âœ”ï¸ Replaced Missing or Inconsistent Fields

Filled null dosage forms

Standardized manufacturer and generic naming

âœ”ï¸ Removed Duplicate Brand Records
ğŸ§  Data Modeling (Star Schema)

Final star schema includes:

Fact Table: Medicines

Dimension Tables: Generics, Drug Class, Dosage Form, Manufacturers, Indication

Relationships were created using:

Generic â†’ Generic Name

Manufacturer â†’ Manufacturer Name

Dosage Form â†’ Dosage Form Name

This ensured correct filtering across visuals.

ğŸ§® DAX Measures (Key)
Manufacturer Competitor Count
Manufacturer Count =
CALCULATE(
    DISTINCTCOUNT(Medicines[Manufacturer Name])
)

Competitor Count per Generic
Generic Competitors =
CALCULATE(
    DISTINCTCOUNT(Medicines[Manufacturer Name]),
    ALLEXCEPT(Medicines, Medicines[Generic Name])
)

Average Price Per Generic
Avg Generic Price = AVERAGE(Medicines[Price])

ğŸ“ˆ Dashboard Highlights
1ï¸âƒ£ Total Number of:

Medicine Brands

Generics

Manufacturers

Drug Classes

Dosage Forms

2ï¸âƒ£ Percentage of Herbal Medicines

Used filtering on Generic Name containing keywords like herbal, herb, etc.

3ï¸âƒ£ Most Common Dosage Form

Bar chart â†’ Count of brands by dosage form
âœ” Tablet emerged as the highest

4ï¸âƒ£ Generic with Highest Number of Medicines

Sorted bar chart
âœ” Paracetamol / other top generic appears at the top

5ï¸âƒ£ Top Drug Class by Number of Generics

âœ” Anti-infective or relevant drug class

6ï¸âƒ£ Most Competitive Manufacturer

Based on highest number of unique brands

ğŸ§ª Specific Problem Statement Answers
âœ” Anti-Malarial â€” Single Competitor?

Filter:

Drug Class contains malaria

Then report generics where:
Generic Competitors = 1

âœ” Entry Price Suggestion for Mefloquine

Compare price distribution of same dosage size

Recommend midpoint of competitor prices
âœ” Ensures competitive entry

âœ” Paracetamol (IV Infusion) Suppliers

Filter:

Generic = Paracetamol

Dosage Form contains â€œIV Infusionâ€
Then count Manufacturer Name

âœ” Competitors for Insulin Medicines

Filter:

Generic Name contains insulin
Count distinct manufacturers
Count distinct brands

âœ” Insulin vs Anti-Hypertensive Competition

Filter generics for:

â€œInsulinâ€

â€œAnti-hypertensiveâ€

Compare:

Manufacturers count

Brand count

ğŸŒŸ Business Insights (Easy to Read)

âœ” Tablet dosage forms dominate â†’ Higher production & adoption
âœ” Herbal medicines have small share â†’ Growth potential
âœ” Some generics have only one competitor â†’ Ideal for new market entry
âœ” Competitive pricing varies by dosage form â†’ Strategy needed per product
âœ” Insulin market highly competitive â†’ Many manufacturers
âœ” Anti-hypertensives show broader competition â†’ Wider market share



ğŸš€ Final Conclusion

This project demonstrates:

Strong Power BI skills

Real-world data cleaning

Star schema modeling

Deep domain analysis

Effective storytelling through dashboards

This analysis can support market entry strategy, pricing, and competitor landscape understanding for pharmaceutical stakeholders.
